Continous Positive Airway Pressure (CPAP) Support for Acute Hypoxemic Respiratory Failure in Burkina Faso

Recruiting N/A Interventional Study
Acute Respiratory Failure
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
240 (estimated)
Sponsor
Université NAZI BONI · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Acute respiratory failure (ARF) is a frequent medical emergency, involving high costs for health organizations and patients who often require intensive care and respiratory assistance. According to an international study, 61% of hypoxemic patients in intensive care receive invasive ventilation \[3\]. Invasive mechanical ventilation is often unavailable in low-income countries and non-invasive vent…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: All patients aged 18 years and older will be included in the study if they meet at least one of the following criteria : * Acute respiratory distress, defined as dyspnea respiratory rate ≥ 25 cycles/min * Hypoxemia, defined as the need for more 6 liters of oxygen to maintain an…
Contacts

Ismael Guibla, doctor

+22676135113

ismaelguibla@gmail.com

CONTACT

Ibrahim Alain Traore, professor

+22671457580

itraore80@gmail.com

CONTACT